Germany · Delayed Price · Currency is EUR Novogenia AG Statistics
Total Valuation
Novogenia AG has a market cap or net worth of EUR 78.00 million. The enterprise value is 31.06 million.
| Market Cap | 78.00M |
| Enterprise Value | 31.06M |
Important Dates
The next estimated earnings date is Wednesday, December 9, 2026.
| Earnings Date | Dec 9, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
Novogenia AG has 12.00 million shares outstanding. The number of shares has decreased by -24.46% in one year.
| Current Share Class | 12.00M |
| Shares Outstanding | 12.00M |
| Shares Change (YoY) | -24.46% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 57.50% |
| Owned by Institutions (%) | 0.10% |
| Float | 5.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.65 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.61, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.61 |
| Quick Ratio | 4.00 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.26 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -18.34% |
| Return on Capital Employed (ROCE) | -10.39% |
| Weighted Average Cost of Capital (WACC) | 5.74% |
| Revenue Per Employee | 256,607 |
| Profits Per Employee | -16,838 |
| Employee Count | 204 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Novogenia AG has paid 1.55 million in taxes.
| Income Tax | 1.55M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.75% in the last 52 weeks. The beta is 0.26, so Novogenia AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -18.75% |
| 50-Day Moving Average | 8.26 |
| 200-Day Moving Average | 8.27 |
| Relative Strength Index (RSI) | 50.25 |
| Average Volume (20 Days) | 546 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novogenia AG had revenue of EUR 52.35 million and -3.43 million in losses. Loss per share was -0.29.
| Revenue | 52.35M |
| Gross Profit | 20.20M |
| Operating Income | -10.59M |
| Pretax Income | -2.08M |
| Net Income | -3.43M |
| EBITDA | -11.02M |
| EBIT | -10.59M |
| Loss Per Share | -0.29 |
Balance Sheet
The company has 39.77 million in cash and 5.71 million in debt, with a net cash position of 34.06 million or 2.84 per share.
| Cash & Cash Equivalents | 39.77M |
| Total Debt | 5.71M |
| Net Cash | 34.06M |
| Net Cash Per Share | 2.84 |
| Equity (Book Value) | 91.77M |
| Book Value Per Share | 7.67 |
| Working Capital | 55.37M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | -439,333 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 38.60%, with operating and profit margins of -20.22% and -6.56%.
| Gross Margin | 38.60% |
| Operating Margin | -20.22% |
| Pretax Margin | -3.97% |
| Profit Margin | -6.56% |
| EBITDA Margin | -21.06% |
| EBIT Margin | -20.22% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.56, which amounts to a dividend yield of 8.65%.
| Dividend Per Share | 0.56 |
| Dividend Yield | 8.65% |
| Dividend Growth (YoY) | -0.44% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 24.46% |
| Shareholder Yield | 33.12% |
| Earnings Yield | -3.98% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Novogenia AG is 19.38, which is 198.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 19.38 |
| Price Target Difference | 198.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 26.77% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on September 18, 2025. It was a forward split with a ratio of 4.
| Last Split Date | Sep 18, 2025 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Novogenia AG has an Altman Z-Score of 4.33 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.33 |
| Piotroski F-Score | 1 |